Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- NVRO
- Price
- 5.84
- Stock movement up
- +- (%)
- Company name
- Nevro Corp
- Exchange
- (NYSE ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 218.83M
- Ent value
- 468.86M
- Price/Sales
- 0.52
- Price/Book
- 0.80
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 9.37%
- 1 year return
- -56.16%
- 3 year return
- -55.71%
- 5 year return
- -42.13%
- 10 year return
- -19.10%
Last updated: 2025-04-12
DIVIDENDS
NVRO does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.52 |
| Price to Book | 0.80 |
| EV to Sales | 1.12 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 37.47M |
| EPS (TTM) | -1.86 |
| FCF per share (TTM) | -1.68 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 419.15M |
| Gross profit (TTM) | 278.09M |
| Operating income (TTM) | -83.14M |
| Net income (TTM) | -69.31M |
| EPS (TTM) | -1.86 |
| EPS (1y forward) | -2.59 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 66.35% |
| Operating margin (TTM) | -19.83% |
| Profit margin (TTM) | -16.54% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 71.98M |
| Net receivables | 70.60M |
| Total current assets | 479.24M |
| Goodwill | 38.21M |
| Intangible assets | 25.14M |
| Property, plant and equipment | 0.00 |
| Total assets | 595.65M |
| Accounts payable | 20.31M |
| Short/Current long term debt | 246.59M |
| Total current liabilities | 95.41M |
| Total liabilities | 322.00M |
| Shareholder's equity | 273.64M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -53.05M |
| Capital expenditures (TTM) | 9.66M |
| Free cash flow (TTM) | -62.71M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -25.33% |
| Return on Assets | -11.64% |
| Return on Invested Capital | -22.25% |
| Cash Return on Invested Capital | -20.13% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 5.84 |
| Daily high | 5.86 |
| Daily low | 5.84 |
| Daily Volume | 754K |
| All-time high | 184.34 |
| 1y analyst estimate | 6.13 |
| Beta | 0.93 |
| EPS (TTM) | -1.86 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 5 May 2025 |
Downside potential
Loading...
Downside potential data
| NVRO | S&P500 | |
| Current price drop from All-time high | -96.83% | -7.90% |
| Highest price drop | -98.22% | -56.47% |
| Date of highest drop | 10 Jan 2025 | 9 Mar 2009 |
| Avg drop from high | -40.32% | -11.07% |
| Avg time to new high | 25 days | 12 days |
| Max time to new high | 1073 days | 1805 days |
COMPANY DETAILS
Marketcap
218.83M
Marketcap category
Small-cap
Description
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.
Employees
1215
Website
Investor relations
-
SEC filings
CEO
D. Keith Grossman
Country
USA
City
Redwood City
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner